Enhancement of vascular permeability by specific activation of protease‐activated receptor‐1 in rat hindpaw: a protective role of endogenous and exogenous nitric oxide
- 1 April 1999
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 126 (8) , 1856-1862
- https://doi.org/10.1038/sj.bjp.0702513
Abstract
1. To clarify the role of the first thrombin receptor/protease-activated receptor (PAR)-1 in an inflammatory process, we tested and characterized the effect of intraplantar (i.pl.) administration of the highly specific PAR-1 agonist TFLLR-NH2 in rat hindpaw. 2. TFLLR-NH2 administered i.pl. at 0.01-0.03 micromol per paw enhanced vascular permeability in the hindpaw and produced paw oedema in a dose-dependent manner. This effect was almost completely abolished by repeated pretreatment with compound 48/80 to deplete inflammatory mediators in mast cells. 3. The NO synthase inhibitor N(G)-nitro-L-arginine methyl ester or N-iminoethyl-L-ornithine, preadministered i.pl., stereospecifically potentiated the i.pl. TFLLR-NH2-induced permeability increase, while the NO donor sodium nitroprusside or NOC-18, given i.pl., suppressed the effect of TFLLR-NH2. 4. These findings demonstrate that specific activation of PAR-1 produces increased vascular permeability accompanied by oedema formation in the rat hindpaw, predominantly via mast cell degranulation, and that endogenous and exogenous NO plays a protective role in the PAR-1-mediated inflammatory event.Keywords
This publication has 42 references indexed in Scilit:
- Increased vascular permeability by a specific agonist of protease‐activated receptor‐2 in rat hindpawBritish Journal of Pharmacology, 1998
- Proteinase-activated receptors: structural requirements for activity, receptor cross-reactivity, and receptor selectivity of receptor-activating peptidesCanadian Journal of Physiology and Pharmacology, 1997
- Ligand Cross-reactivity within the Protease-activated Receptor FamilyJournal of Biological Chemistry, 1996
- Thrombin functions as an inflammatory mediator through activation of its receptor.The Journal of Experimental Medicine, 1996
- Protease-mediated signalling: new paradigms for cell regulation and drug developmentTrends in Pharmacological Sciences, 1996
- Nitric oxide: The Jekyll and Hyde of gut inflammationInflammation Research, 1993
- Thrombin-Mediated Increase in Vascular Endothelial PermeabilitySeminars in Thrombosis and Hemostasis, 1992
- Impairment of the L-arginine-nitric oxide pathway in mast cells from spontaneously hypertensive ratsBiochemical and Biophysical Research Communications, 1991
- Rat mast cells synthesize a nitric oxide like-factor which modulates the release of histamineInflammation Research, 1991
- Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activationCell, 1991